Iduronate 2-sulfatase (IDS, EC 3.1.6.13) is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations causing IDS deficiency in humans result in the lysosomal storage of these glycosaminoglycans and Hunter syndrome, an X chromosome-linked disease. We have isolated and sequenced a 2.3-kilobase cDNA clone coding for the entire sequence of human IDS. Analysis of the deduced 550-amino acid IDS precursor sequence indicates that IDS has a 25-amino acid amino-terminal signal sequence, followed by 8 amino acids that are removed from the proprotein. An internal proteolytic cleavage occurs to produce the mature IDS present in human liver shown to contain a 42-kDa polypeptide N-terminal to a 14-kDa polypeptide. The IDS sequence has strong sequence homology with other sulfatases (such as sea urchin arylsulfatase, human arylsulfatases A, B, and C, and human glucosamine 6-sulfatase), suggesting that the sulfatases comprise an evolutionarily related family of genes that arose by gene duplication and divergent evolution. The arylsulfatases have a greater homology with each other than with the nonarylsulfatases (IDS and glucosamine 6-sulfatase). The IDS cDNA detected RNA species of 5.7, 5.4, 2.1, and 1.4 kilobases in human placental RNA and revealed structural alterations and gross deletions of the IDS gene in many of the clinically severe Hunter syndrome patients studied.
Iduronate 2-sulfatase (IDS, EC 3.1.6.13) acts as an exosulfatase in lysosomes to hydrolyze the C2-sulfate ester bond from non-reducing-terminal iduronic acid residues in the glycosaminoglycans heparan sulfate and dermatan sulfate (1) . IDS is one of a family of at least nine sulfatases that hydrolyze sulfate esters in human cells. They are all lysosomal enzymes that act on sulfated monosaccharide residues in a variety of complex substrates with the exception of microsomal steroid sulfatase (or arylsulfatase C), which acts on sulfated 3,8-hydroxysteroids (1, 2) . Each sulfatase displays absolute substrate specificity, making the sulfatase family an attractive model to investigate the molecular requirements for substrate binding and the catalysis of sulfate ester hydrolysis.
A deficiency in the activity of IDS in humans leads to the lysosomal accumulation of heparan sulfate and dermatan sulfate fragments and their excretion in urine (1) . This storage results in the clinical disorder Hunter syndrome (mucopolysaccharidosis type II, MPS-II) in which patients may present with variable phenotypes from severe mental retardation, skeletal deformities, and stiff joints to a relatively mild course (1) . It has been postulated that this clinical heterogeneity reflects different mutations at the IDS locus affecting enzyme expression, stability, or function. MPS-II is one of the most common mucopolysaccharidoses and is the only one that is X chromosome-linked (1) .
We have reported (3) the purification of IDS from human liver and other tissues and in this communication we report the nucleotide sequence for a full-length cDNA clone for IDSt from human endothelial cells. We present data demonstrating sequence homology with other sulfatases and the detection of deletions and rearrangements in the IDS gene of severely affected MPS-II patients.
MATERIALS AND METHODS
Materials. Form A of IDS was purified from human liver as described (3) . Restriction endonucleases, polynucleotide kinase, T4 DNA ligase, the Klenow fragment of DNA polymerase I, and M13 sequencing kits were from Boehringer Mannheim. GeneScreenPlus nylon filters were from DuPont/NEN. [y-32P]ATP (5000 Ci/mmol; 1 Ci = 37 GBq), [a-32P]dCTP (3000 Ci/mmol), and Multiprime DNA labeling kit were from Amersham. Oligo(dT)-cellulose and Sephadex G-50 were from Pharmacia P-L Biochemicals. The X chromosome genomic library LAOXNLO1 was from the American Tissue Culture Collection, and the Agt1O random-primed human colon cDNA library (1.5 x 106 independent clones) and the Agtll human endothelial cDNA library (2.1 x 106 independent clones) were from Clontech.
Polypeptide Isolation and Sequencing. Approximately 20 ,tg ofform A liver IDS was subjected to SDS/polyacrylamide gel electrophoresis and transferred to an Immobilon P membrane (Millipore) (4) with modifications of overnight preelectrophoresis of the SDS/polyacrylamide gel and the addition of 200 ,ul of 100 mM sodium thioglycollate to the cathode buffer chamber before electrophoresis. The 42-kDa and the 14-kDa polypeptides were excised and directly amino-terminal sequenced by Bresatec (Adelaide, Australia).
Library Screening. A 49-mer oligonucleotide sequence (3'-ACTAGTAGCACCTGCTGGACGCCGGGAGGGAC-CCGCTGATGCTGCTGCA-5') was designed from the amino-terminal amino acid sequence (using residues 8-24 of *To whom reprint requests should be addressed.
tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. M38371).
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TCCTTCCTCTGAGAAGTATGAAAAsCACTAAGACATGTCGAGGGCCAGATGGAGAACTCCATGCCAACCTGCTTTGCCCTGTGGATGTGCTGGATGTTCCCGAGGGCACCTTGCCTGACAA 720 read- ing frame that included a sequence that was colinear with the 42-kDa and the 14-kDa amino-terminal amino acid sequences. However, the reading frame did not extend to include a stop codon or any 3' untranslated region. A 300-bp HindIII-EcoRI restriction fragment from the 3' end of the Ac2S15 was then used to screen a cDNA library constructed from human endothelial cells. Twenty-seven clones were isolated; 5 of which were also positive to the amino-terminalspecific 49-mer. Of the five, the clone that contained the longest insert (2.3 kb; Ac2S23) was sequenced in combination with Ac2S15. Fig. 1 shows the nucleotide sequence of the 2297-bp insert from Ac2S23, which encodes the entire amino acid sequence of IDS. Except for a few differences, the deduced amino acid sequence was colinear with the determined amino-terminal amino acid sequence of the 42-kDa and 14-kDa polypeptides. We believe that the amino acid discrepancies (residues 35,53, 55, and 57) between the direct and predicted amino acid sequence data reflect amino acid sequencing errors resulting from the low signal obtained toward the end ofthe amino acid sequencing run. The detection of gene deletions and rearrangements in DNA from a group of severely affected MPS-II patients when hybridized with Ac2S15 established that these cDNA clones encoded IDS ( Fig. 2A) Fig. 2A-) had the most severe clinical phenotype of the large group of MPS-II patients studied, raising the possibility that these patients may also have codeletions of contiguous genes to IDS (unpublished data).
The sequence of Ac2S23 shown in Fig. 1 (12) . Two putative sites for cleavage between the signal sequence and mature protein are indicated by arrows (Fig. 1) . It would appear that eight amino acids are removed from the IDS precursor immediately after the most favored signal peptidase cleavage site (12) between residues 25 and 26. The 14-kDa polypeptide amino-terminal amino acid sequence was identified at amino acid residue 456, giving a total of 95 amino acids to the carboxyl terminus. The full sequence contains eight possible N-glycosylation sites (Asn-Xaa-Ser/ Thr, Fig. 1 (13) .
Northern blot analysis of placental poly(A)+ RNA with Ac2S15 revealed three major RNA species (5.7, 5.4, and 2.1 kb) and one minor species (1.4 kb) (Fig. 2B) . It (16) . Differential polyadenylylation can account for the three major species but it cannot explain the 1.4-kb minor species, which is too small to encode the full IDS protein. It is possible that the 1.4-kb species represents a degradation product or a cross-reacting species, although it is also possible that it results from a process of differential splicing to produce another protein product, as has been observed for the human lysosomal enzymes, for example, /3-glucuronidase (17) and /3-galactosidase (18) . The 520 bp of 3' untranslated region in Ac2S23 contains a potential polyadenylylation signal (AATAAA) at position 2041 that may direct the position of polyadenylylation for the observed 2.1-kb mRNA species. If this is the case, the 124 bp of 5' untranslated region in Ac2S23 is sufficient to account for most, if not all, of the 5' untranslated region expected for the 2.1-kb mRNA species [allowing for 50-100 residues of poly(A) tail]. Fig. 3 shows an alignment of IDS amino acid sequence with sequence of other human-derived sulfatases and a sea urchin
arylsulfatase. This analysis reveals many areas of identical and conserved amino acid matches within the arylsulfatase group (galactose 3-sulfatase, N-acetylgalactosamine 4-sulfatase, and steroid sulfatase) and the two nonarylsulfatase sequences (unpublished data), IDS and glucosamine 6-sulfatase. Sea urchin arylsulfatase is also aligned and has sequence homology with the other five human sulfatases. A multiple sequence alignment of the amino acid sequence of these six sulfatases has the highest level of homology in the amino-terminal third of each sulfatase (Fig. 3) . The human arylsulfatase group has conserved blocks of up to six identical amino acid residues, for example, Cys-Thr-Pro-Ser-Arg and Gly-Lys-Trp-His-Leu-Gly (Fig. 3) . On the other hand, only part of these sequences are conserved in the two nonarylsulfatases, IDS and glucosamine 6-sulfatase. We propose that these sequences may represent regions of the arylsulfatases that enable the relatively nonspecific hydrolysis of arylsulfates. All five human sulfatases have significant sequence homology with the amino acid sequence of sea urchin arylsulfatase (Fig. 3) . By taking account of conservative amino acid substitutions (23) , there are even larger areas of homology within these six sulfatases. This high level of sequence conservation further supports the suggestion that these five human sulfatases are evolutionarily related to a common ancestral gene (14, 15, 19) . There are several regions in Fig. 3 where peptide inserts appear to be unique to a particular sulfatase. For instance, the microsomal membrane-bound steroid sulfatase contains two membrane-spanning regions (Fig. 3) (21) . IDS also contains an amino acid sequence insert in the same region as the second membrane-spanning region of steroid sulfatase (Fig.  3) . A second peptide insert in IDS is present just before the (14) , human N-acetylgalactosamine 4-sulfatase or arylsulfatase B (15), human steroid sulfatase or arylsulfatase C (20, 21) , and sea urchin arylsulfatase (22) shown in lines 2, 6, A, B, C, and U, respectively. Amino acids identical in all sulfatases are boxed. Amino acids identical in the arylsulfatase activities (lines A, B, C, and U) are starred on the bottom line. The ringed residues in lines 2, 6, and B indicate the first amino-terminal amino acid in polypeptides produced by internal proteolysis.
Underlined sequences are unique to each particular sulfatase sequence and underlined and starred sequences are blocks of conserved residues (see text for discussion).
amino-terminal sequence of the 14-kDa polypeptide. The role that these two peptide inserts may have in IDS function is unknown. Interestingly, the sites (ringed in Fig. 3 ) for internal proteolysis of both glucosamine 6-sulfatase (19) and N-acetylgalactosamine 4-sulfatase (unpublished data) also occur near the sequence inserts. Although this may be coincidental, it is tempting to speculate that internal proteolysis may occur at or near these sites for IDS, glucosamine 6-sulfatase, and N-acetylgalactosamine 4-sulfatase.
Peters et al. (15) have speculated that the histidine residue in the highly conserved Gly-Lys-Trp-His-Leu-Gly region (Fig. 3) of the arylsulfatases, the conserved arginine residues in and nearby the Leu-Cys-Thr-Pro-Ser-Arg region (Fig. 3) , and the Thr-Gly-Arg-Xaa-Xaa-Val-Arg region may contain the catalytic residues required for sulfate ester hydrolysis. This hypothesis was supported by evidence from studies reporting that one histidine residue (24) and two or more arginine residues (25) are essential for the catalytic activity of galactose 3-sulfatase (arylsulfatase A). However, the histidine and all but one arginine residue are eliminated from these regions when IDS and glucosamine 6-sulfatase are included in the family of sulfatases.
The isolation of cDNA encoding IDS will initiate in-depth studies of mutations causing the Hunter clinical phenotype. The observation that IDS amino acid sequence reduces the number of residues that are conserved in the sulfatase family will aid studies designed to identify catalytic site residues and perhaps also identify those residues involved in determining substrate specificity.
